Is SONN or QYLD a better dividend investment in 2026?

SONN currently yields 158.73% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: SONN offers higher current income.

What is the dividend yield difference between SONN and QYLD?

SONN has a forward dividend yield of 158.73% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 146.81 percentage points.

Home › Compare › SONN vs QYLD

SONN vs QYLD: Dividend Comparison 2026

SONN yields 158.73% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SONN wins by $33.41M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SONN

● Live price

158.73%

Share price

$1.26

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$33.43M

Annual income

$14,929,974.02

Full SONN calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — SONN vs QYLD

📍 SONN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SONN	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SONN + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SONN pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SONN

Annual income on $10K today (after 15% tax)

$13,492.06/yr

After 10yr DRIP, annual income (after tax)

$12,690,477.92/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, SONN beats the other by $12,685,667.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SONN + QYLD for your $10,000?

SONN: 50%QYLD: 50%

100% QYLD50/50100% SONN

Portfolio after 10yr

$16.73M

Annual income

$7,467,816.67/yr

Blended yield

44.64%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SONN right now

SONN

Analyst Ratings

Buy

Consensus: Buy

Altman Z

-14.0

Piotroski

3/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SONN buys

QYLD buys

No recent congressional trades found for SONN or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSONNQYLD

Forward yield	158.73% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$33.43M ✓	$25.4K
Annual income after 10y	$14,929,974.02 ✓	$5,659.31
Total dividends collected	$31.06M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: SONN vs QYLD ($10,000, DRIP)

Year	SONN Portfolio	SONN Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$26,573	$15,873.02	$10,352	$1,192.36	+$16.2K → SONN
2	$67,853	$39,419.99	$10,830	$1,347.57	+$57.0K → SONN
3	$166,675	$94,072.29	$11,460	$1,539.07	+$155.2K → SONN
4	$394,305	$215,962.78	$12,275	$1,777.84	+$382.0K → SONN
5	$899,388	$477,481.77	$13,323	$2,078.95	+$886.1K → SONN
6	$1,980,205	$1,017,859.40	$14,667	$2,463.34	+$1.97M → SONN
7	$4,213,254	$2,094,435.11	$16,396	$2,960.57	+$4.20M → SONN
8	$8,672,949	$4,164,766.74	$18,631	$3,612.97	+$8.65M → SONN
9	$17,292,333	$8,012,278.11	$21,548	$4,482.15	+$17.27M → SONN
10	$33,432,771	$14,929,974.02	$25,398	$5,659.31	+$33.41M → SONN

SONN vs QYLD: Complete Analysis 2026

SONN — Stock

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey.

Full SONN Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this SONN vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SONN vs SCHD SONN vs JEPI SONN vs O SONN vs KO SONN vs MAIN SONN vs XYLD SONN vs JEPQ SONN vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.